StonvexLoading…
StonvexStonvexStonvexCore line items from BNZI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $12.16M | $4.53M | $4.56M | $5.33M |
Operating Income | $-18.46M | $-13.47M | $-9.80M | $-6.21M |
Net Income | $-22.49M | $-31.51M | $-14.41M | $-15.47M |
EPS (Diluted) | $-5.95 | $-69.75 | $-6.00 | $-2.40 |
Total Assets | $31.63M | $25.67M | $5.29M | $5.48M |
Total Liabilities | $23.58M | $28.44M | $37.16M | $29.59M |
Cash & Equivalents | $259.20K | $1.09M | $2.09M | $1.02M |
Free Cash Flow OCF − CapEx | Not available | Not available | $-1.55M | $-5.18M |
Shares Outstanding | 10.55M | 819.52K | 2.59M | 6.45M |